TipRanks Black Friday Sale
- Claim 60% off TipRanks Premium for the data-backed insights and research tools you need to invest with confidence.
- Subscribe to TipRanks' Smart Investor Picks and see our data in action through our high-performing model portfolio - now also 60% off
Organon ( (OGN) ) has provided an announcement.
Organon reported its third-quarter 2025 financial results, showing a slight increase in revenue to $1.602 billion, up 1% as-reported but down 1% excluding foreign currency impacts. The company lowered its full-year revenue guidance to $6.200 billion to $6.250 billion and adjusted EBITDA margin to approximately 31.0%. The quarter saw a decline in women’s health revenue by 3% as-reported, while biosimilars revenue increased by 19% due to strong performance of certain products. Organon is focusing on cost discipline and debt reduction to create capacity for future growth opportunities.
The most recent analyst rating on (OGN) stock is a Hold with a $7.00 price target. To see the full list of analyst forecasts on Organon stock, see the OGN Stock Forecast page.
Spark’s Take on OGN Stock
According to Spark, TipRanks’ AI Analyst, OGN is a Neutral.
Organon’s overall stock score is primarily impacted by its financial challenges, including declining revenue and high leverage. Technical analysis indicates a bearish trend, further weighing on the score. However, the stock’s valuation appears attractive with a low P/E ratio and high dividend yield, providing some support. The earnings call provided a mixed outlook, with strategic debt repayment and guidance raise as positives.
To see Spark’s full report on OGN stock, click here.
More about Organon
Organon operates in the pharmaceutical industry, focusing on women’s health, biosimilars, and established brands. The company is committed to delivering impactful medicines and solutions, with a market focus on generating significant free cash flow and pursuing growth opportunities in women’s health.
Average Trading Volume: 4,922,197
Technical Sentiment Signal: Sell
Current Market Cap: $1.76B
Find detailed analytics on OGN stock on TipRanks’ Stock Analysis page.